16 Publications
2019
Social correlates of mental health in gastrointestinal cancer patients and their family caregivers: Exploring the role of loneliness
Secinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinRand, Kevin LRand, Kevin LRand, Kevin LRand, Kevin LJohns, Shelley AJohns, Shelley AJohns, Shelley AJohns, Shelley AO'Neil, Bert HO'Neil, Bert HO'Neil, Bert HO'Neil, Bert HHelft, Paul RHelft, Paul RHelft, Paul RHelft, Paul RShahda, SafiShahda, SafiShahda, SafiShahda, SafiJalal, Shadia IJalal, Shadia IJalal, Shadia IJalal, Shadia IMosher, Catherine EMosher, Catherine EMosher, Catherine E and Mosher, Catherine E
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, vol. 27, (no. 6), pp. 2086, 2019-Jun. | Journal Article
2018
Clinical Characteristics of Patients Experiencing Pathologic Complete Response Following Neoadjuvant Therapy for Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma
Hashemi-Sadraei, NedaHashemi-Sadraei, NedaGbolahan, Olumide BGbolahan, Olumide BSalfity, HaiSalfity, HaiO'Neil, BertO'Neil, BertHouse, Michael GHouse, Michael GShahda, Safi and Shahda, Safi
American journal of clinical oncology, vol. 41, (no. 10), pp. 985, 2018-10-00. | Journal Article
 
Examining the effect of peer helping in a coping skills intervention: a randomized controlled trial for advanced gastrointestinal cancer patients and their family caregivers
Mosher, CatherineMosher, CatherineMosher, CatherineMosher, CatherineMosher, CatherineMosher, CatherineMosher, CatherineMosher, CatherineMosher, CatherineMosher, CatherineMosher, CatherineMosher, Catherine EMosher, CatherineSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinJohns, ShelleyJohns, ShelleyJohns, ShelleyJohns, ShelleyJohns, ShelleyJohns, ShelleyJohns, ShelleyJohns, ShelleyJohns, ShelleyJohns, ShelleyJohns, Shelley AJohns, ShelleyJohns, ShelleyO’Neil, BertO’Neil, BertO’Neil, BertO’Neil, BertO’Neil, BertO’Neil, BertO’Neil, BertO’Neil, BertO'Neil, Bert HO’Neil, BertO’Neil, BertO’Neil, BertO’Neil, BertHelft, PaulHelft, PaulHelft, PaulHelft, PaulHelft, PaulHelft, PaulHelft, Paul RHelft, PaulHelft, PaulHelft, PaulHelft, PaulHelft, PaulHelft, PaulShahda, SafiShahda, SafiShahda, SafiShahda, SafiShahda, SafiShahda, SafiShahda, SafiShahda, SafiShahda, SafiShahda, SafiShahda, SafiShahda, SafiShahda, SafiJalal, ShadiaJalal, Shadia IJalal, ShadiaJalal, ShadiaJalal, ShadiaJalal, ShadiaJalal, ShadiaJalal, ShadiaJalal, ShadiaJalal, ShadiaJalal, ShadiaJalal, ShadiaJalal, ShadiaChampion, VictoriaChampion, VictoriaChampion, VictoriaChampion, VictoriaChampion, VictoriaChampion, VictoriaChampion, Victoria LChampion, VictoriaChampion, VictoriaChampion, VictoriaChampion, VictoriaChampion, Victoria and Champion, Victoria
Quality of Life Research, vol. 27, (no. 2), pp. 528, 20180200. | Journal Article
2016
Abstract B35: Molecular and phenotypic profiling of pancreatic cancer cachexia in novel murine models and patients
Zimmers, Teresa AZimmers, Teresa AZimmers, Teresa AZimmers, Teresa AZimmers, Teresa AZimmers, Teresa AZimmers, Teresa AJiang, YanlinJiang, YanlinJiang, YanlinJiang, YanlinJiang, YanlinJiang, YanlinJiang, YanlinLiu, JianguoLiu, JianguoLiu, JianguoLiu, JianguoLiu, JianguoLiu, JianguoLiu, JianguoCeppa, EugeneCeppa, EugeneCeppa, EugeneCeppa, EugeneCeppa, EugeneCeppa, EugeneCeppa, EugeneNakeeb, AtillaNakeeb, AtillaNakeeb, AtillaNakeeb, AtillaNakeeb, AtillaNakeeb, AtillaNakeeb, AtillaHouse, MichaelHouse, MichaelHouse, MichaelHouse, MichaelHouse, MichaelHouse, MichaelHouse, MichaelZyromski, NicholasZyromski, NicholasZyromski, NicholasZyromski, NicholasZyromski, NicholasZyromski, NicholasZyromski, NicholasSchmidt, C. MaxSchmidt, C. MaxSchmidt, C. MaxSchmidt, C. MaxSchmidt, C. MaxSchmidt, C. MaxSchmidt, C. MaxHannaford, KatharynHannaford, KatharynHannaford, KatharynHannaford, KatharynHannaford, KatharynHannaford, KatharynHannaford, KatharynSchloss, DanielSchloss, DanielSchloss, DanielSchloss, DanielSchloss, DanielSchloss, DanielSchloss, DanielBrooks, CynthiaBrooks, CynthiaBrooks, CynthiaBrooks, CynthiaBrooks, CynthiaBrooks, CynthiaBrooks, CynthiaRadovich, MilanRadovich, MilanRadovich, MilanRadovich, MilanRadovich, MilanRadovich, MilanRadovich, MilanLui, YunlongLui, YunlongLui, YunlongLui, YunlongLui, YunlongLui, YunlongLui, YunlongJiang, GuanglongJiang, GuanglongJiang, GuanglongJiang, GuanglongJiang, GuanglongJiang, GuanglongJiang, GuanglongKonieczny, Stephen FKonieczny, Stephen FKonieczny, Stephen FKonieczny, Stephen FKonieczny, Stephen FKonieczny, Stephen FKonieczny, Stephen FSchweickert, PatrickSchweickert, PatrickSchweickert, PatrickSchweickert, PatrickSchweickert, PatrickSchweickert, PatrickSchweickert, PatrickHancock, BradHancock, BradHancock, BradHancock, BradHancock, BradHancock, BradHancock, BradKayes, JoshuaKayes, JoshuaKayes, JoshuaKayes, JoshuaKayes, JoshuaKayes, JoshuaKayes, JoshuaZhong, XiaolingZhong, XiaolingZhong, XiaolingZhong, XiaolingZhong, XiaolingZhong, XiaolingZhong, XiaolingPoirier, ChristophePoirier, ChristophePoirier, ChristophePoirier, ChristophePoirier, ChristophePoirier, ChristophePoirier, ChristopheAu, ErnieAu, ErnieAu, ErnieAu, ErnieAu, ErnieAu, ErnieAu, ErnieBonetto, AndreaBonetto, AndreaBonetto, AndreaBonetto, AndreaBonetto, AndreaBonetto, AndreaBonetto, AndreaShahda, SafiShahda, SafiShahda, SafiShahda, SafiShahda, SafiShahda, SafiShahda, SafiKohli, MarcKohli, MarcKohli, MarcKohli, MarcKohli, MarcKohli, MarcKohli, MarcO'Neil, BertO'Neil, BertO'Neil, BertO'Neil, BertO'Neil, BertO'Neil, BertO'Neil, BertPons, MariannePons, MariannePons, MariannePons, MariannePons, MariannePons, MariannePons, MarianneKoniaris, LeonidasKoniaris, LeonidasKoniaris, LeonidasKoniaris, LeonidasKoniaris, LeonidasKoniaris, Leonidas and Koniaris, Leonidas
Cancer Research, vol. 76, (no. 24 Supplement), pp. B35, 2016-12-15. | Journal Article
 
Abstract B51: Regulation of HIF1α under hypoxia by APE1/Ref-1 impacts CA9 expression: Dual-targeting in patient-derived 3D pancreatic cancer models
Logsdon, Derek PLogsdon, Derek PLogsdon, Derek PLogsdon, Derek PGrimard, MichelleGrimard, MichelleGrimard, MichelleGrimard, MichelleShahda, SafiShahda, SafiShahda, SafiShahda, SafiZyromski, NicholasZyromski, NicholasZyromski, NicholasZyromski, NicholasSchipani, ErnestinaSchipani, ErnestinaSchipani, ErnestinaSchipani, ErnestinaCarta, FabrizioCarta, FabrizioCarta, FabrizioCarta, FabrizioSupuran, Claudiu TSupuran, Claudiu TSupuran, Claudiu TSupuran, Claudiu TKorc, MurrayKorc, MurrayKorc, MurrayKorc, MurrayIvan, MirceaIvan, MirceaIvan, MirceaIvan, MirceaKelley, Mark RKelley, Mark RKelley, Mark RKelley, Mark RFishel, Melissa LFishel, Melissa LFishel, Melissa L and Fishel, Melissa L
Cancer Research, vol. 76, (no. 24 Supplement), pp. B51, 2016-12-15. | Journal Article
 
Abstract B85: Pathologic complete response following systemic chemotherapy with or without chemoradiotherapy for borderline resectable/unresectable pancreatic adenocarcinoma: Indiana University experience
Hashemi-Sadraei, NedaHashemi-Sadraei, NedaNguyen, HaiNguyen, HaiO'Neil, BertO'Neil, BertHouse, Michael GHouse, Michael GShahda, Safi and Shahda, Safi
Cancer Research, vol. 76, (no. 24 Supplement), pp. B85, 2016-12-15. | Journal Article
 
Abstract B88: Clinical trials targeting APE1/Ref-1 in pancreatic cancer with APX3330
Kelley, Mark RKelley, Mark RShahda, SafiShahda, SafiO'Neil, Bert HO'Neil, Bert HPearce, HomerPearce, HomerWalling, Jackie and Walling, Jackie
Cancer Research, vol. 76, (no. 24 Supplement), pp. B88, 2016-12-15. | Journal Article
 
A phase Ib study of cancer stem cell (CSC) pathway inhibitor BBI-608 in combination with gemcitabine and nab-paclitaxel (nab-PTX) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC)
Shahda, SafiEl-Rayes, Bassel FO'Neil, Bert HStarodub, AlexanderHanna, Wahid TewfikBorodyansky, LauraOh, CindyLi, Chiang and Bekaii-Saab, Tanios S
Journal of Clinical Oncology, vol. 34, (no. 4_suppl), pp. 284, 2016-02-01. | Journal Article
 
Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers
Radovich, MilanRadovich, MilanRadovich, MilanRadovich, MilanRadovich, MilanKiel, Patrick JKiel, Patrick JKiel, Patrick JKiel, Patrick JKiel, Patrick JNance, Stacy MNance, Stacy MNance, Stacy MNance, Stacy MNance, Stacy MNiland, Erin ENiland, Erin ENiland, Erin ENiland, Erin ENiland, Erin EParsley, Megan EParsley, Megan EParsley, Megan EParsley, Megan EParsley, Megan EFerguson, Meagan EFerguson, Meagan EFerguson, Meagan EFerguson, Meagan EFerguson, Meagan EJiang, GuanglongJiang, GuanglongJiang, GuanglongJiang, GuanglongJiang, GuanglongAmmakkanavar, Natraj RAmmakkanavar, Natraj RAmmakkanavar, Natraj RAmmakkanavar, Natraj RAmmakkanavar, Natraj REinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HCheng, LiangCheng, LiangCheng, LiangCheng, LiangCheng, LiangNassiri, MehdiNassiri, MehdiNassiri, MehdiNassiri, MehdiNassiri, MehdiDavidson, Darrell DDavidson, Darrell DDavidson, Darrell DDavidson, Darrell DDavidson, Darrell DRushing, Daniel ARushing, Daniel ARushing, Daniel ARushing, Daniel ARushing, Daniel ALoehrer, Patrick JLoehrer, Patrick JLoehrer, Patrick JLoehrer, Patrick JLoehrer, Patrick JPili, RobertoPili, RobertoPili, RobertoPili, RobertoPili, RobertoHanna, NasserHanna, NasserHanna, NasserHanna, NasserHanna, NasserCallaghan, J ThomasCallaghan, J ThomasCallaghan, J ThomasCallaghan, J ThomasCallaghan, J ThomasSkaar, Todd CSkaar, Todd CSkaar, Todd CSkaar, Todd CSkaar, Todd CHelft, Paul RHelft, Paul RHelft, Paul RHelft, Paul RHelft, Paul RShahda, SafiShahda, SafiShahda, SafiShahda, SafiShahda, SafiO'Neil, Bert HO'Neil, Bert HO'Neil, Bert HO'Neil, Bert HO'Neil, Bert HSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PSchneider, Bryan P and Schneider, Bryan P
Oncotarget, vol. 7, (no. 35), pp. 56500, 2016-Aug-30. | Journal Article
 
Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models
Logsdon, Derek PLogsdon, Derek PLogsdon, Derek PLogsdon, Derek PLogsdon, Derek PLogsdon, Derek PLogsdon, Derek PGrimard, MichelleGrimard, MichelleGrimard, MichelleGrimard, MichelleGrimard, MichelleGrimard, MichelleGrimard, MichelleLuo, MeihuaLuo, MeihuaLuo, MeihuaLuo, MeihuaLuo, MeihuaLuo, MeihuaLuo, MeihuaShahda, SafiShahda, SafiShahda, SafiShahda, SafiShahda, SafiShahda, SafiShahda, SafiJiang, YanlinJiang, YanlinJiang, YanlinJiang, YanlinJiang, YanlinJiang, YanlinJiang, YanlinTong, YanTong, YanTong, YanTong, YanTong, YanTong, YanTong, YanYu, ZhangshengYu, ZhangshengYu, ZhangshengYu, ZhangshengYu, ZhangshengYu, ZhangshengYu, ZhangshengZyromski, NicholasZyromski, NicholasZyromski, NicholasZyromski, NicholasZyromski, NicholasZyromski, NicholasZyromski, NicholasSchipani, ErnestinaSchipani, ErnestinaSchipani, ErnestinaSchipani, ErnestinaSchipani, ErnestinaSchipani, ErnestinaSchipani, ErnestinaCarta, FabrizioCarta, FabrizioCarta, FabrizioCarta, FabrizioCarta, FabrizioCarta, FabrizioCarta, FabrizioSupuran, Claudiu TSupuran, Claudiu TSupuran, Claudiu TSupuran, Claudiu TSupuran, Claudiu TSupuran, Claudiu TSupuran, Claudiu TKorc, MurrayKorc, MurrayKorc, MurrayKorc, MurrayKorc, MurrayKorc, MurrayKorc, MurrayIvan, MirceaIvan, MirceaIvan, MirceaIvan, MirceaIvan, MirceaIvan, MirceaIvan, MirceaKelley, Mark RKelley, Mark RKelley, Mark RKelley, Mark RKelley, Mark RKelley, Mark RKelley, Mark RFishel, Melissa LFishel, Melissa LFishel, Melissa LFishel, Melissa LFishel, Melissa LFishel, Melissa L and Fishel, Melissa L
Molecular cancer therapeutics, vol. 15, (no. 11), pp. 2732, 2016-11-00. | Journal Article
2015
Abstract B167: APX3330 drug development for clinical trials targeting APE1/Ref-1 in pancreatic cancer
Fishel, Melissa LFishel, Melissa LFishel, Melissa LCheng, HuiwenCheng, HuiwenCheng, HuiwenShahda, SafiShahda, SafiShahda, SafiKelley, Mark RKelley, Mark R and Kelley, Mark R
Molecular Cancer Therapeutics, vol. 14, (no. 12 Supplement 2), pp. B167, 2015-12-00. | Journal Article
2014
GI-4000 in KRAS mutant cancers.
Shahda, Safi and O'Neil, Bert
Expert opinion on investigational drugs, vol. 23, (no. 2), pp. 273-278, February 2014. | Journal Article
 
Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in locally advanced unresectable pancreatic cancer.
Chiorean, Elena GSchneider, Bryan PAkisik, Fatih MPerkins, Susan MAnderson, StephenJohnson, Cynthia SDe Witt, JohnHelft, PaulClark, RomneeJohnston, Erica LSpittler, A JDeluca, JillBu, GuixueShahda, SafiLoehrer, Patrick JSandrasegaran, Kumar and Cardenes, Higinia R
International journal of radiation oncology, biology, physics, vol. 89, (no. 2), pp. 284-91, 2014/Jun/1. | Journal Article
2013
Abstract 1911: Analysis of the pancreatic cancer (PC) genome by immunohistochemistry (IHC) and comparative genome hybridization (CGH) in patients with long term survival with metastatic disease (mPC) treated on a phase II molecular profiling trial
Shahda, SafiShahda, SafiBarrett, Michael TBarrett, Michael TLenkiewicz, ElizabethLenkiewicz, ElizabethEvers, LisaEvers, LisaPosner, Richard GPosner, Richard GAziz, MerajAziz, MerajWeiss, Glen JWeiss, Glen JJameson, GayleJameson, GayleVon Hoff, Daniel DVon Hoff, Daniel DRamanathan, Ramesh K and Ramanathan, Ramesh K
Cancer Research, vol. 73, (no. 8 Supplement), pp. 1911, 2013-04-15. | Journal Article
2012
APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival.
Cardoso, Angelo ACardoso, Angelo AJiang, YanlinJiang, YanlinLuo, MeihuaLuo, MeihuaReed, April MReed, April MShahda, SafiShahda, SafiHe, YingHe, YingMaitra, AnirbanMaitra, AnirbanKelley, MarkKelley, Mark RFishel, Melissa L and Fishel, Melissa L
PloS one, vol. 7, (no. 10), pp. e47462, 2012. | Journal Article
2011
The human metapneumovirus: a case series and review of the literature.
Shahda, SCarlos, William GKiel, P JKhan, Babar and Hage, C A
Transplant infectious disease : an official journal of the Transplantation Society, vol. 13, (no. 3), pp. 324-8, 2011/Jun. | Journal Article